Generex has received the patent titled ‘Mixed Micellar Pharmaceutical Delivery System and Method of Preparation’ from The Commissioner of the Japan Patent Office. The patent number 449282 is
Mr Davis had previously served as corporate vice president and chief financial officer for Baxter. Concurrent with this change, Robert Hombach has been named corporate vice president and
Victoza is a once-daily human GLP-1 analogue for the treatment of type 2 diabetes. The price approval allows Novo Nordisk to launch in Japan shortly after Victoza is
Mr Weyer will lead Amylin’s R&D organization, focusing on expanding opportunities with the company’s existing diabetes products, advancing the obesity and early diabetes pipeline, and driving research programs
Findings from Abraxis BioScience phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab(R)) driven chemotherapy, nab-paclitaxel (Abraxane for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable
Martin Gleave, executive director of Vancouver Prostate Centre, said: “Knowing that our two organisations hold similar mandates, this collaboration with CDRD ensures that we are maximising our resources
Medidata has started ASPire to Win in April 2005, as a channel partner program designed to enable select CROs and other service providers to offer Medidata Rave implementation
Reportedly, Tetraphase will use the funds to advance its pipeline of antibiotics, into Phase 1 and Phase 2 clinical studies. The company’s TP-434, a broad spectrum intravenous (IV)
For more than 30 years, Accupac has served pharmaceutical and consumer products companies by offering customized contract manufacturing and packaging solutions. Working within an FDA and cGMP environment,
Reportedly, the Diocese of Sunyani will be the sole distributor for all drugs manufactured by AGP Ghana. The partnership will allow priority access to Catholic Mission Hospitals in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.